Home Page Contact Us Site Map
Home    Articles      Facts      Charity      Lawyers      Directory      Add a Link      Clinical Trials
Statins Reverse Doxorubicin Resistance in Mesothelioma Cells
Statins reverse doxorubicin resistance in human malignant mesothelioma cells in culture ...more
83 Year Old Man Dies from Mesothelioma Days After Winning Compensation
AN employee of a former ice cream factory has died of an asbestos-related disease ...more
New Research Findings
New Research Findings Published In National Academy Of Sciences Journal ...more
Air quality agency collects record asbestos fines
The Bay Area Air Quality Management District has collected $430,000 in asbestos fines ...more
Professor from Loyola joins isle cancer center
Dr. Michele Carbone, lead investigator for two National Cancer Institute grants ...more
CuraGen and TopoTarget Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for Mesothelioma
Announced today the initiation of patient dosing in a Phase II clinical trial evaluating the activity of PXD101 ...more
Actor Paul Gleason dies from Mesothelioma
'The Breakfast Club' actor Paul Gleason dies at 67 ...more
Professor from Loyola joins isle cancer center

Professor from Loyola joins isle cancer center

June 25, 2006

Dr. Michele Carbone, lead investigator for two National Cancer Institute grants totaling $3.5 million, has joined the Cancer Research Center of Hawaii.

Carbone is coming here from Loyola University Medical Center's Cardinal Bernadin Cancer Center in Chicago, where he was a professor in the Department of Pathology, Thoracic Oncology Program.

He will be associate director of basic sciences at the Hawaii Cancer Research Center and head a newly created Thoracic Oncology Program.

"I'm excited that a scientist of Dr. Carbone's caliber has joined the Cancer Research Center," said director Dr. Carl-Wilhelm Vogel. "He will significantly strengthen our research efforts in the understanding of the pathogenesis of lung cancer, particularly mesothelioma."

Carbone has spent much of his career studying thoracic cancer, with emphasis in malignant mesothelioma, a relatively rare cancer of the lining of the chest and abdomen caused by asbestos.

Findings of his research team on malignant mesothelioma were published June 20 in the Proceedings of the National Academy of Sciences of the U.S.A. and in the online and print editions of the June 23 Nature Reviews Cancer.

Besides the NCI grants to investigate the relationship of asbestos to mesothelioma, Carbone has received substantial grants from the American Cancer Society and National Institutes of Health.

Carbone is from a family of physicians in Italy, where he received his medical degree from the Medical School of Rome La Sapienza.

He earned a doctorate degree in human pathology through a combined program of the Medical School of Rome and National Institutes of Health in the United States.

He has a medical license as an anatomic pathologist. His research lab will be in the new Biomedical Research Building in the John A. Burns School of Medicine's Kakaako complex.

Source: Hawaii - Star Bulletin


General Information About Malignant Mesothelioma
Stages of Malignant Mesothelioma
Asbestos Exposure: Q & A
Mesothelioma: Q & A
Metastatic Cancer: Q & A
Cancer of Unknown Primary Origin
Treatment Options Overview
Treatment Options for Malignant Mesothelioma
To Learn More
If you or someone you love has recently been diagnosed with malignant mesothelioma, then find out the necessary facts about your legal rights by requesting FREE information.
Articles       Facts       Charity       Lawyers       Directory       Add a Link       Clinical Trials       State Coverage